BRD4 Antikörper (C-Term)
Kurzübersicht für BRD4 Antikörper (C-Term) (ABIN927765)
Target
Alle BRD4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Kreuzreaktivität
- Maus, Ratte (Rattus), Hund, Rind (Kuh)
-
Aufreinigung
- Purified
-
Immunogen
- BRD4 antibody was raised in rabbit using the C terminal of BRD4 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
BRD4 Blocking Peptide, (ABIN937853), is also available for use as a blocking control in assays to test for specificity of this BRD4 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- BRD4 (Bromodomain Containing 4 (BRD4))
-
Andere Bezeichnung
- BRD4
-
Hintergrund
- BRD4 is homologous to the murine protein MCAP, which associates with chromosomes during mitosis, and to the human RING3 protein, a serine/threonine kinase. Each of these proteins contains two bromodomains, a conserved sequence motif which may be involved in chromatin targeting. Synonyms: Polyclonal BRD4 antibody, Anti-BRD4 antibody, bromodomain containing 4 antibody, CAP antibody, HUNKI antibody, MCAP antibody.
-
Pathways
- Chromatin Binding, SARS-CoV-2 Protein Interaktom
Target
-